Is there or is there not a place for anti-interferon antibodies in the decision making of multiple sclerosis treatment optimisation?
N. Grigoriadis; G. Deretzi; N. Artemis; N. Tascos; I. Milonas
- 作者N. Grigoriadis; G. Deretzi; N. Artemis; N. Tascos; I. Milonas
- 卷第27卷
- 印刷ISSN1590-1874
- 电子ISSN1590-3478
- 文件大小38.47KB
- 发表时间2006-09
- DOI10.1007/s10072-006-0693-9